DCF — JERSEY CITY MEDICAL CENTER
Enterprise Value: $-960.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-960.8M
Enterprise Value
$-299.6M
PV of Cash Flows
$-661.2M
PV of Terminal Value
$-1.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $470.5M | $-62.3M | -13.0% | $-82.2M | $-74.7M |
| Year 2 | $484.6M | $-59.3M | -12.0% | $-79.8M | $-65.9M |
| Year 3 | $499.1M | $-56.1M | -11.0% | $-77.2M | $-58.0M |
| Year 4 | $514.1M | $-55.2M | -11.0% | $-76.9M | $-52.5M |
| Year 5 | $529.5M | $-55.5M | -10.0% | $-77.9M | $-48.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-960.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$456.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13731161844474998
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5